Originally published byEU-Startups
TidalSense (formerly Cambridge Respiratory Innovations), a Cambridge-based AI-powered respiratory diagnostic, today announced a €16.6 million ($19 million) funding round to accelerate commercialisation in the UK and support globalisation of the technology, including to the USA. The round included investment from new investor Cross-Border Impact Ventures, and returning investors BGF, Airstream Capital, and Foresight Group. This […]
The post Cambridge’s TidalSense raises €16.6 million to turn the tide on respiratory diagnostics with patented AI tech appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Bypassing AI guardrails is so easy a script kiddie can do it
5h ago
As Larry Ellison bets the farm, Oracle says it loves AI-written code, just not in OpenJDK
1d ago
AI is 'both the weapon and the target' in latest wave of cyberattacks
1d ago
Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics
1d ago
Unexpected item in the bagging area as Windows Activation error pops up at check-in
3d ago